IL17A and adenocarcinoma: It was reported that IL17 signaling is required for the transition of prostatic intraepithelial neoplasia to adenocarcinoma and that IL17 promotes development of invasive prostate adenocarcinoma under castrate conditions by the experiments using IL17 receptor-knockout Pten-deficient model mice [83,84].